Moderna Inc.’s shares fell in late trading after US regulators refused to review its novel mRNA flu vaccine, dealing a major ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

The Girard Free Library will host a K9s For Compassion program at 6 p.m. today where children up to age 12 can read ...

Pick two.” But a team from the University of Virginia School of Medicine has discovered a way to make vaccines that embrace ...

Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...

The vaccine maker’s shots involve the successful mRNA technology used in the Covid vaccines. Health Secretary Robert F.

Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called ...

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA ...

In a news release late Tuesday, Moderna said it was blindsided by the FDA’s refusal, which the FDA cited as being due to the design of the company’s Phase 3 trial for its mRNA flu vaccine, dubbed mRNA ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...